0001144204-17-044233.txt : 20170818 0001144204-17-044233.hdr.sgml : 20170818 20170818180109 ACCESSION NUMBER: 0001144204-17-044233 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170816 FILED AS OF DATE: 20170818 DATE AS OF CHANGE: 20170818 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KLEMP WALTER V CENTRAL INDEX KEY: 0000938419 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37758 FILM NUMBER: 171041858 MAIL ADDRESS: STREET 1: 1415 WEST LOOP NORTH CITY: HOUSTON STATE: TX ZIP: 77055 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Moleculin Biotech, Inc. CENTRAL INDEX KEY: 0001659617 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 474671999 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2575 WEST BELLFORT STREET 2: SUITE 333 CITY: HOUSTON STATE: TX ZIP: 77054 BUSINESS PHONE: 713-300-5160 MAIL ADDRESS: STREET 1: 2575 WEST BELLFORT STREET 2: SUITE 333 CITY: HOUSTON STATE: TX ZIP: 77054 4 1 v473535_4.xml FORM 4 X0306 4 2017-08-16 0 0001659617 Moleculin Biotech, Inc. MBRX 0000938419 KLEMP WALTER V C/O MOLECULIN BIOTECH, INC. 2575 WEST BELLFORT, SUITE 333 HOUSTON TX 77054 1 1 1 0 Chief Executive Officer Common Stock 2017-08-16 4 S 0 100000 1.703 D 967724 D The reporting person entered into a private sale agreement for the shares of common stock set forth in the table. The 12,000 shares of common stock purchased by the reporting person on May 11, 2017 are a matching transaction under Section 16 of the Securities Exchange Act of 1934 with 12,000 shares of common stock sold by the reporting person as set forth in the table above. In Accordance with Section 16, the reporting person will disgorge to the issuer an aggregate short-swing profit of $10,716. In addition to the shares held directly by the reporting person, the reporting person is the majority shareholder and control person of Annamed, Inc. Annamed, Inc. holds 1,425,000 shares of Issuer common stock. The Pursuant to General Instruction 5(b)(iv) of Form 3, the amount set forth in the table represents the reporting person's proportionate interest in the Issuer common stock beneficially owned by Annamed, Inc. /s/ Walter Klemp 2017-08-18